ImmunXperts, a Q² Solutions Company ImmunXperts, a Q² Solutions Company

Menu
  • Home
  • Services
    • Immunogenicity
    • Immuno-Oncology
    • Cell Therapy
    • ImmunAcademy
  • About Us
    • Team
    • Scientific Advisory Board
  • News & Events
  • Contact Us
  • Careers

You are here:

  1. Home
  2. News & Events
  3. Advances in Immuno-Oncology 2018

Advances in Immuno-Oncology 2018

30 April 2018

Meet ImmunXperts at the 3rd Annual Advances in Immuno-Oncology Congress held on 24-25 May 2018, in London, UK.

www.immunooncology-congress.com

Posted in:
  • Events

See more

  1. Prev:European Neoantigen Summit 2018
  2. Back: All Posts
  3. Next:World Preclinical Congress 2018

Recent Posts

  • In vitro Immunogenicity and Functional Testing of Nanoparticles, mRNA, and Biologics
  • Happy to join the Nexelis family
  • 11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
  • Innovation for Health
  • PEGS Europe, 18-22 November 2019, Lisbon

Categories

  • Events
  • News
  • Uncategorized
 
  • linkedin
  • twitter

Services

  • Immunogenicity
  • Immuno-Oncology
  • Cell Therapy
  • ImmunAcademy

About Us

  • Team
  • Scientific Advisory Board

News & Events

  • News
  • Events
Website by Uchrony
  • Home
  • Contact Us
  • Careers

© ImmunXperts, a Q² Solutions Company | Rue Auguste Piccard 48 6041 Gosselies | +32(0)71960133


Contact Us
Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions.
Learn more at www.q2labsolutions.com.

Back to Top